Eli Lilly Balance Sheet Health
Financial Health criteria checks 1/6
Eli Lilly has a total shareholder equity of $10.9B and total debt of $25.4B, which brings its debt-to-equity ratio to 233.4%. Its total assets and total liabilities are $64.0B and $53.1B respectively. Eli Lilly's EBIT is $10.8B making its interest coverage ratio 34.5. It has cash and short-term investments of $3.0B.
Key information
233.4%
Debt to equity ratio
US$25.36b
Debt
Interest coverage ratio | 34.5x |
Cash | US$3.04b |
Equity | US$10.86b |
Total liabilities | US$53.14b |
Total assets | US$64.01b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LLY's short term assets ($25.7B) do not cover its short term liabilities ($27.3B).
Long Term Liabilities: LLY's short term assets ($25.7B) do not cover its long term liabilities ($25.8B).
Debt to Equity History and Analysis
Debt Level: LLY's net debt to equity ratio (205.4%) is considered high.
Reducing Debt: LLY's debt to equity ratio has increased from 95.1% to 233.4% over the past 5 years.
Debt Coverage: LLY's debt is not well covered by operating cash flow (16.7%).
Interest Coverage: LLY's interest payments on its debt are well covered by EBIT (34.5x coverage).